peopleInnovationCareers RarePipelineCollaborationFinanceAdvance treatment Skip to main contentSkip to navigationSkip to search
HNSA   ( ,  %) SEK
Quotes are delayed 15 minutes
Doctor writing on a notepad

Investigator sponsored trials 

We value and welcome independent and ethical research performed by third-party investigators as an important contribution to our mission to develop innovative lifesaving and life altering therapies for patients with rare immunological diseases.

Investigators are welcome to submit study concepts (i.e. investigator sponsored trials or ISTs) to Hansa Biopharma along with requests to provide either funding, drug product, or both. The study concept must be supported by a valid study design and meaningful objectives, compliant with privacy rights, and in complete respect of the safety and welfare of participants.

Contact us 

Investigators can reach out to Hansa Biopharma's medical science liaison (MSL) or alternatively email our Investigator Sponsored Trial Review Committee at The committee will facilitate contact with the responsible MSL in the interested geographical location. Once connection is established, our MSL will serve as the point of contact throughout the submission and review process.